Exceptional case of synchronous colon cancers with different MMR status provides direct in vivo evidence of ICI responsiveness differences. (Japanese Journal of Clinical Oncology)
MSI-H tumor responds to immunotherapy while MSI-stable tumor does not in same patient
The CRC Digest